Soliton, Inc. (SOLY)

[RichardSawars]

Soliton Announces Significant Discovery of Acoustic Subcision for Treatment of Cellulite

Source: PR Newswire (US)
HOUSTON, June 4, 2019 /PRNewswire/ -- Soliton, Inc., (NASDAQ: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced results of preclinical studies of the use of a new version of its acoustic pulse technology which reveal its RAP device appears to be capable of selective disruption of the fibrotic septa that contribute to the appearance of cellulite.